Life Science Professional
Dr Teja Rus is a Volunteer Writer at BioNews. Teja has a background in molecular genetics and over a decade of research experience in onco-immunology and therapy development. She completed her PhD at Cardiff University, focusing on the potential of blood γδ T cells in anti-cancer vaccine development, followed by her post-doctoral work in the Netherlands investigating development and role of tissue resident T cells in panceratic cancer. Previously, she contributed to research on cancer genetics at CRUK Cambridge Institute, and translational research on genetic modification of cardiac patients' iPSCs at Leiden University Medical Centre in the Netherlands. Now, she applies that depth of expertise to medical publications and affairs, bridging cutting-edge research innovations in myeloma and onco-immunology with communications that help bring new treatments to patients.
Rare variants in the FNIP1 gene are linked to lower body fat, less liver fat, a more favourable fat distribution and around 60 percent lower odds of cardiometabolic disease, according to the largest exome-sequencing study of energy metabolism to date...
A transplant of genome-edited stem cells designed to protect healthy donor cells from cancer therapy has shown promise in patients with aggressive blood cancers...
Human stem cells edited to evade immune responses survived for five months in mice without triggering rejection...
A new multipurpose genome editing approach could address around a third of rare genetic diseases...
Reducing the activity of a single protein by half can significantly suppress tumour growth across multiple cancer types, according to new research...
A precision genome editing approach has successfully corrected harmful mutations in mitochondrial DNA, offering new hope for treating currently incurable mitochondrial diseases...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
